I agree with you 1000% regarding a partnership. But where
I agree with you 1000% regarding a partnership. But where are they? And (I get the impression that Nader likes to "do it my way." Not sure, that's just an impression I get.
Nader also keeps talking about making a case based on "unmet need." We definitely have unmet need. Sadly. It's horrific. So if leronlimab proves safe and effective, even using secondary endpoints and the FDA delays us, we need a plan of action.
So another route to consider is this: We need champions in government. We also need champions in major media who will cry foul if we prove this drug is effective (which I believe we will.) Who are our champions? Is everyone prepared to write/call their congresspeople/senators? Governors, even? Can we put our heads together and think "who do we know?" of "who do we know who knows someone?" I've been scouring the rolodesk of my mind. (Just dated myself LOL) I lived in NYC for over 20 years and I used to know so many people in media, but now I can't really think of anyone I'm in touch with.
7
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Lilly's Breakthrough in Diabetes Treatment Eli Lilly's retatrutide is stirring up the diabetes treatment waters. The latest Phase 3 comparison to Ozempic's top dose reveals some surprising results. I'm not one to toss out kudos lightly, but this could be a genuine game-changer if things hold steady. A1C Reductions: A Close Look at the Numbers We’re staring down the...
Continue Reading
An Honor from The Inner Circle Sometimes, in a field stuffed with brilliant minds, a beacon stands out. That's Dr. Michael M. Pennock for you—a man who doesn’t just treat cancer patients but transforms their journeys with precision and empathy. Recognized as a Pinnacle Lifetime Member by The Inner Circle, Pennock’s dedication in the field of radiation oncology is...
Continue Reading
Untangling the Surge in Infection Control Demand Lately, it's like every healthcare joint worldwide is scrambling for better infection control. We're talking about a market poised to jump from a whopping USD 58.5 billion in 2026 to USD 80.2 billion by 2031—a tidy 37% uptick. That change, brewing at a 6.5% CAGR, speaks volumes about where the industry's heading. What's...
Continue Reading
High-Risk Lending Meets Military Protections Ever seen a seemingly legal scheme that just leaves a sour taste? That's the vibe with CashNetUSA right now. They've landed in the hot seat over allegedly sky-high interest rates served up to folks who put on a uniform. We're talking about a proposed nationwide class action lawsuit accusing the lender of giving active-duty...
Continue Reading
Shanghai Beckons: A Game Changer for Danobatgroup One crisp morning in Shanghai marks a turning point for Danobatgroup. The Spanish heavy-hitter in machine tools has pinpointed the Shanghai Xinzhuang Industry Park in Minhang District for its Asia-Pacific headquarters. It ain't just another blip on the radar—this one's a calculated leap. Location, Location, Location...
Continue Reading
A Fresh Force in Legal Tech: FluxCap Debuts Alright, strap in because the legal world just got itself a new team in the majors. FluxCap is breaking out into the open, promising to shake up how big, gnarly cases get tackled. These aren't just any cases; we're talking the kind that keep antitrust knuckles white and palms sweaty. It's like watching seasoned racecar drivers...
Continue Reading
Clip's Strategic Move with Pulpos Clip just laid down a serious marker in the digital payment world by snagging Pulpos, a firm that’s got its claws deep into AI-driven business management software. This move isn't just some fancy headline. It's a real, grounded step in expanding Clip's ecosystem to bolster the backbone of Mexico's economy: small and medium-sized...
Continue Reading
The Battle Against Drug Resistance Heats Up Folks, we're in a never-ending fight here against one of the toughest adversaries out there: lung cancer. And lemme tell ya, when drugs show resistance, it's like trying to punch a ghost. But there’s a fresh wind blowing, as Dr. Bobak Parang steps up to the plate with a $620K grant aimed squarely at tackling drug resistance in...
Continue Reading
Unpacking Sony's Latest Sensor: LYTIA 720 Tell me, when was the last time a tech drop made you shake your head in awe? Sony just pulled one of those moves with their latest toy, the LYTIA 720. We're talking a 50-effective megapixel CMOS image sensor crafted for mobile warriors, and it packs a punch that should have the competition looking over their shoulder. Dazzling...
Continue Reading
Orlando Sets the Stage for Luxury Expansion Well, it seems Orlando's hospitality scene is about to get a significant bump. Civitas Capital Group just tossed a cool $386 million into the pot for the construction of a 700-key luxury hotel on the infamous International Drive. We're not talking about just another hotel here; this one's a real beast, a future InterContinental...
Continue Reading
Top 5 Most Recently Viewed Articles
Overview of Financial Performance Orbit Garant Drilling Inc. (TSX: OGD) has released its financial results for the first quarter of fiscal 2026, ending on September 30, 2025. During this three-month period, the company recorded a revenue of $46.7 million, marking a 3.7% decline compared to $48.4 million during the same period last year. The revenue figures reflect a range...
Continue Reading
Celebrating Achievements in Real Estate Leadership The Leadership Awards highlight the dedication of Coldwell Banker-affiliated real estate professionals who embody the core values of the organization. Recognizing Outstanding Contributions With a strong commitment to innovation and community service, Coldwell Banker Real Estate LLC, a subsidiary of Anywhere Real Estate...
Continue Reading
Major Shift in U.S. Drone Production Policies The recent announcement from the U.S. Defense Secretary has ignited excitement in the drone manufacturing industry. On a significant day, the Secretary unveiled plans to fast-track drone production through reforms aimed at simplifying procurement processes within the Pentagon. This bold move signifies a departure from previous...
Continue Reading
Exciting Announcement from Acacia Research Acacia Research Corporation (NASDAQ: ACTG) is poised to share its financial outcomes for the third quarter of 2024. This revelation is set to occur before the market opens on a significant day in November. Businesses and investors alike are eager to gain insights into the company’s latest financial endeavors. What to Expect...
Continue Reading
Revolutionizing Grocery Retail with Deliverect's Innovative Solution Deliverect, a leader in food technology software as a service (SaaS), has introduced Deliverect Retail to enhance the digital shopping experience for groceries. This important development allows grocery retailers to operate more effectively, which leads to better sales and improves customer satisfaction....
Continue Reading